0000899243-21-025309.txt : 20210622
0000899243-21-025309.hdr.sgml : 20210622
20210622171844
ACCESSION NUMBER: 0000899243-21-025309
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210621
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2019 GP, L.L.C.
CENTRAL INDEX KEY: 0001845038
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40489
FILM NUMBER: 211036274
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2019, L.P.
CENTRAL INDEX KEY: 0001845041
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40489
FILM NUMBER: 211036272
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2019 GP, L.P.
CENTRAL INDEX KEY: 0001845039
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40489
FILM NUMBER: 211036273
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PKWY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verve Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840574
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824800132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (978) 501-3026
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-21
0
0001840574
Verve Therapeutics, Inc.
VERV
0001845038
GV 2019 GP, L.L.C.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
0001845039
GV 2019 GP, L.P.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
0001845041
GV 2019, L.P.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
Common Stock
2021-06-21
4
C
0
4029244
A
4029244
I
By GV 2019 L.P.
Common Stock
2021-06-21
4
C
0
443265
A
4472509
I
By GV 2019 L.P.
Series A-2 Preferred Stock
2021-06-21
4
C
0
37308792
D
Common Stock
4029244
0
I
By GV 2019 L.P.
Series B Preferred Stock
2021-06-21
4
C
0
4104416
D
Common Stock
443265
0
I
By GV 2019 L.P.
The Series A-2 Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series A-2 Preferred Stock had no expiration date.
The reported securities are held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2019 GP, L.P., GV 2019 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
/s/ Daphne Chang, Authorized Signatory
2021-06-22